Bookmark this article! [?]

BlinkbitsBlinkListsBlogLinesBlogmarksBuddymarksCiteULikeCo.mmentsDel.icio.usDiggDiigo

FarkFeed Me LinksFurlGoogleLinkagogoma.gnoliaMister WongNewsvinePropellerRawsugar

RedditRojoSimpySphinnSpurlSquidooStumbleUponTailrankTechnoratiYahoo

Background

Severe, often refractory anemia is characteristic of the myelodysplastic syndrome associated with chromosome 5q31 deletion. We investigated whether lenalidomide (CC5013) could reduce the transfusion requirement and suppress the abnormal 5q31– clone in patients with this disorder. Methods One hundred...